Odonate Therapeutics, Inc.
DelistedCIK 1717452fmd_1GBDR3GGQCMHZCEXFC5AFZEM3AManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2017 to Sep 30, 2021, 19 periods
| Line item | FY2017 | FY2018 | FY2019 | FY2020 |
|---|---|---|---|---|
| Research and development | 28 | 80 | 104 | 117 |
| Total operating expenses | 33 | 91 | 115 | 127 |
| Operating income | (33) | (91) | (115) | (127) |
| Income tax expense | 0 | 0 | 0 | 0 |
| Net income | (33) | (89) | (112) | (126) |